Abstract:The constitutively active tyrosine kinase Bcr-Abl fusion protein is essential for the development of chronic myeloid leukaemia. Inhibitors of its tyrosine kinase activity e.g. Imatinib, are highly effective in treating chronic phase disease but are only transiently useful in blast crisis, especially lymphoid blast crisis. Bcl-6 is a transcriptional repressor that is required for the formation and maintenance of germinal centre B-cells. Following reports that Imatinib increases expression of Bcl-6 in Ph+ cell lines representative of lymphoid blast crisis we have investigated the regulation of this molecule and its functional importance. We utilised BV173 and Z119. Basal Bcl-6 protein expression was detectable in Z119, but not BV173. As anticipated Imatinib increased Bcl-6 expression in both cell lines. STAT5 is an important target of Bcr-Abl and has been implicated as both a positive and negative regulator of Bcl-6 transcription. Transient transfection with a mammalian expression plasmid bearing a dominant negative STAT5 reduced Bcl-6 expression in Z119 implying that activated STAT5 promotes Bcl-6 expression in this cell line, but also that STAT5 cannot be the main target of Bcr-Abl because Imatinib and dominant negative STAT5 have opposing effects. Next we considered the possibility that phosphorylation status of the transcription factor FoxO3a, which has been shown to bind to the Bcl-6 promoter, correlated with Bcl-6 expression. We found that decreased phosphorylation of Foxo3a, activating this transcription factor, was highly associated with increased Bcl-6 expression suggesting that it is an significant Bcr-Abl target. Next we wished to find out the functional implications of increased Bcl-6 expression. We found that a low concentration of Imatinib (0.25μM) was sufficient to induce Bcl-6 in BV173 and Z119, and caused death of these cell lines over several days. Next we combined Imatinib with a previously reported peptide antagonist of the Bcl-6/SMRT co-repressor interaction. Neither this peptide nor a mutated negative control peptide had an effect on cell numbers or apoptosis over 48 hours of culture when used alone. However, when combined with Imatinib the wild-type peptide, but not the control, reduced cell growth in Z119. We conclude that Bcl-6 may be a survival factor in Ph+ lymphoid blast crisis cell lines following treatment with Imatinib and that specific treatments to abrogate Bcl-6 function may find a place in the treatment of lymphoid blast crisis of CML.

Direct Transcriptional Regulation of Bim by FoxO3a Mediates STI571-induced Apoptosis in Bcr-Abl-expressing Cells

FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines

Disruption Of The Inhibitor Of Apoptosis Protein Survivin Sensitizes Bcr-Abl-Positive Cells To Sti571-Induced Apoptosis

FoxO3a and BCR-ABL Regulate <i>cyclin D2</i> Transcription through a STAT5/BCL6-Dependent Mechanism

BIM Induction of Apoptosis Triggered by EGFR-sensitive and Resistance Cell Lines of Non-Small-cell Lung Cancer

FoxO3a and BCR-ABL Regulatecyclin D2Transcription Through a STAT5/BCL6-Dependent Mechanism

FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel treated breast cancer cell lines.

[STI571 Induces Apoptosis of K562 Cells Through Down-Regulation of Anti-Apoptotic Protein Mcl-1 and Bcl-xl Expression].

The Mechanism of STI571 Inducing Apoptosis of K562 Cells.

Overexpression of BimSs3, the Novel Isoform of Bim, Can Trigger Cell Apoptosis by Inducing Cytochrome C Release from Mitochondria.

FOXO3a Induces Differentiation of Bcr-Abl-transformed Cells Through Transcriptional Down-Regulation of Id1.

BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3

Bcl-6 May Be a Survival Factor in Pre-B Cell Ph+ Blast Crisis Cell Lines.

Abstract 1727: Evidence That E2F1-mediated Upregulation of Bim, a Proapoptotic BH3-only Protein, Functions As a Prosurvival Molecule in Cancer.

Bim, a Proapoptotic Protein, Up-regulated via Transcription Factor E2F1-dependent Mechanism, Functions as a Prosurvival Molecule in Cancer

BimL directly neutralizes Bcl-xL to promote Bax activation during UV-induced apoptosis

Evidence That E2F1‐mediated Upregulation of Bim, a Proapoptotic BH3‐only Protein, Functions As a Prosurvival Molecule in Cancer

Macrophage Migration Inhibitory Factor (mif) Interacts with Bim and Inhibits Bim-Mediated Apoptosis

ER stress triggers apoptosis by activating BH3-only protein Bim

Bcr-Abl drives the formation of Hsp70/Bim PPI to stabilize oncogenic clients and prevent cells from undergoing apoptosis

[Role of dysregulation of Bim in resistance of melanoma cells to endoplasmic reticulum stress-induced apoptosis].